Drug Trial Radar · NCT06564974
Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
Last checked: Nov 20, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
250
Planned (sponsor's estimate)
Start
Sep 25, 2024
Primary completion
Feb 2032
Study completion Feb 2032
Sponsor
- Lead sponsor
- Catalyst Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- ICON plc; Veeva Systems; Children's Hospital of Eastern Ontario; Medpace, Inc.
- First posted
- Aug 21, 2024
Design
- Study type
- Observational
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study is to collect additional information on the safety of long-term treatment with AGAMREE® and to explore long-term clinical impact of AGAMREE® on quality of life, as assessed by standardized patient-reported outcome measures (QoL questionnaires) in male patients aged 2 years and older with Duchenne muscular dystrophy (DMD).
Conditions
- Duchenne Muscular Dystrophy
Interventions
VamoroloneDrug
Study treatment is AGAMREE®, which is commercially available as an oral suspension.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Height z-scoreTime frame: At Enrollment Visit (baseline), and at each Yearly Follow-up Visit (for up to 5 years).
- Change in BMI z-scoreTime frame: At Enrollment Visit (baseline), and each Yearly Follow-up Visit (for up to 5 years)
- Change in North Star Ambulatory Assessment from baselineTime frame: At Enrollment visit, and each Yearly Follow-up Visit (for up to 5 years).
- Change in Performance of Upper Limb from baselineTime frame: At Enrollment Visit, at each Yearly Follow-up Visit (for up to 5 years).
- Tanner stage documentationTime frame: At Enrollment Visit (baseline), at each Yearly Follow-up Visit (for up to 5 years).
- Percentage of patients with cataract and/or glaucomaTime frame: At Enrollment (baseline), and during each Yearly Follow-up Visit (for up to 5 years).
- Findings from lateral spine x-rayTime frame: At Enrollment Visit (baseline), and during each Yearly Follow-up Visit (for up to 5 years).
- Findings from anterior-posterior/posterior-anterior X-rayTime frame: At Enrollment Visit (baseline), and at each Yearly Follow-Up Visit (for up to 5 years).
- Findings from hand-wrist X-rayTime frame: At Enrollment Visit (baseline), and each Yearly Follow-Up Visit (for up to 5 years).
- Summary statistics of bone mineral density measures assessed by dual x-ray absorptiometryTime frame: At Enrollment Visit (baseline) and each Yearly Follow-Up Visit (for up to 5 years).
- Body Composition Mass MeasuresTime frame: At Enrollment Visit, each Yearly Follow-Up and End of Study/Early Termination (for approximately 5 years).
- Summary statistics of body fat percentage and regional fat distribution ratios assessed by DXATime frame: At Enrollment visit, each Yearly Follow-up visit, and End of study/Early termination (for approximately 5 years).
- Findings from standard of care echocardiographyTime frame: At Enrollment Visit, and at each Yearly Follow-up Visit (for up to 5 years).
- Frequency and percentage of participants experiencing any adverse events and serious adverse eventsTime frame: From informed consent, Enrollment visit, each Yearly follow-up visit, and End of Study/Early Termination (for up to 5 years).
- Findings from cardiac magnetic resonance imaging (subset of patients taking part in the cardiac sub-study only)Time frame: Enrollment Visit, and at each Yearly Follow-Up Visit (for up to 5 years).
- Presence of cardiomyopathy assessed by echocardiography using transmural strain profile (only in a subset of patients taking part in the cardiac sub-study)Time frame: At Enrollment Visit (baseline), and each Yearly Follow-up Visit (for up to 5 years) or Early Termination.
Locations
33 sites in 2 countries. Site status is shown where the registry gives one.
Phoenix Children's Hospital
Phoenix, Arizona · Recruiting
Arkansas Childrens Hospital
Little Rock, Arkansas · Enrolling by invitation
Loma Linda University Pediatric Subspecialty Clinics
Loma Linda, California · Recruiting
Children's Hospital Los Angeles
Los Angeles, California · Not yet recruiting
Valley Children's Hospital
Madera, California · Not yet recruiting
Stanford University
Palo Alto, California · Not yet recruiting
University of California, Davis
Sacramento, California · Recruiting
Children's National Health System
Washington D.C., District of Columbia · Not yet recruiting
University of Florida Clinical and Translational Science Institue
Gainesville, Florida · Recruiting
University of Miami
Miami, Florida · Not yet recruiting
Nicklaus Children's Hospital
Miami, Florida · Enrolling by invitation
Nemours Children's Hospital
Orlando, Florida · Enrolling by invitation
Johns Hopkins All Children's Hospital
St. Petersburg, Florida · Recruiting
Lurie Children's Hospital of Chicago
Chicago, Illinois · Enrolling by invitation
Indiana University Health - Riley Hospital for Children
Indianapolis, Indiana · Enrolling by invitation
University of Kansas Medical Center
Kansas City, Kansas · Enrolling by invitation
University of Massachusetts Memorial Medical Center
North Worcester, Massachusetts · Enrolling by invitation
Helen DeVos Children's Hospital
Grand Rapids, Michigan · Enrolling by invitation
Masonic Children's Hospital - Discovery Clinic
Minneapolis, Minnesota · Not yet recruiting
The Children's Hospital at Montefiore
The Bronx, New York · Not yet recruiting
Atrium Health Neurosciences Institute
Charlotte, North Carolina · Enrolling by invitation
Duke University Medical Center and Childrens Health Center
Durham, North Carolina · Enrolling by invitation
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio · Recruiting
Penn State Milton S. Hershey Medical Center- Penn State Hershey Neuroscience Institute
Hershey, Pennsylvania · Enrolling by invitation
Children's Hospital of Philadelphia (CHOP)
Philadelphia, Pennsylvania · Enrolling by invitation
University of Texas Southwestern Medical Center
Dallas, Texas · Enrolling by invitation
Neurology Rare Disease Center - Neurology & Neuromuscular Care Center
Denton, Texas · Enrolling by invitation
The University of Texas Health Science Center at San Antonio
San Antonio, Texas · Recruiting
University of Virginia Health System (UVAHS) - Pediatric Neuromuscular Center
Charlottesville, Virginia · Enrolling by invitation
Seattle Children's Hospital
Seattle, Washington · Enrolling by invitation
Children's Wisconsin
Milwaukee, Wisconsin · Not yet recruiting
San Jorge Children's Hospital
San Juan, Puerto Rico, Puerto Rico · Recruiting
FDI Clinical Research
San Juan, Puerto Rico, Puerto Rico · Enrolling by invitation
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.